Direxion Daily S&P Biotech Bull 3X ETF
LABU
33 hedge funds and large institutions have $42.4M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 7 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 3
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
59% more capital invested
Capital invested by funds: $26.6M → $42.4M (+$15.8M)
18% more funds holding
Funds holding: 28 → 33 (+5)
0.01% more ownership
Funds ownership: 0.22% → 0.22% (+0.01%)
4% less call options, than puts
Call options by funds: $85.7M | Put options by funds: $89.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.3M |
| 2 |
CG
Cutler Group
San Francisco,
California
|
+$5.38M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.19M |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3.05M |
| 5 |
RCM
Requisite Capital Management
Dallas,
Texas
|
+$2.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$7.14M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
-$1.98M |
| 3 |
XSC
X-Square Capital
Guaynabo,
Puerto Rico
|
-$414K |
| 4 |
MIC
Means Investment Company
Bangor,
Maine
|
-$288K |
| 5 |
VF
Virtu Financial
New York
|
-$271K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $7K | +$5.74K | +6 | +150% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
CA
28
Cornerstone Advisory
Hunt Valley,
Maryland
| $4K | +$4.79K | +5 | New |
|
29
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | +$3.83K | +4 | New |
|
30
Walleye Trading
New York
| $3K | +$3.83K | +4 | New |
|
|
SCA
31
Snowden Capital Advisors
New York
| $2K | +$2.87K | +3 | New |
|
|
AWM
32
Activest Wealth Management
Aventure,
Florida
| $1K | – | – | – |
|
|
TWA
33
TCI Wealth Advisors
Tucson,
Arizona
| $1K | +$957 | +1 | New |
|
|
HF
34
HRT Financial
New York
| – | -$7.14M | -6,454 | Closed |
|
|
FTUS
35
Flow Traders U.S.
New York
| – | -$1.98M | -1,788 | Closed |
|
|
MIC
36
Means Investment Company
Bangor,
Maine
| – | -$288K | -260 | Closed |
|
|
VF
37
Virtu Financial
New York
| – | -$271K | -245 | Closed |
|
|
SWM
38
Spire Wealth Management
Mclean,
Virginia
| – | -$11K | -10 | Closed |
|
|
IF
39
Ironwood Financial
Tucson,
Arizona
| – | -$6K | -6 | Closed |
|
40
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$6K | -5 | Closed |
|
LABU Hedge Fund Activity: Q4 2021 in Review
33 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2021, worth a combined $42.4M — up 59% from $26.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LABU positions and 7 closed out — a net gain of 5 holders — while 15 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $14.3M. The largest seller was HRT Financial, exiting entirely with an estimated $7.14M sold.
- 33 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2021, up from 28 in Q3 2021.
- Funds reported $42.4M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2021, up 59% quarter-over-quarter.
- 12 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2021 and 7 closed out, a net change of +5 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2021 was Citadel Advisors, an estimated $14.3M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2021 was HRT Financial, an estimated $7.14M sold.
Based on aggregated 13F filings for Q4 2021.